Literature DB >> 29961974

Topical timolol: An effective treatment option for agminated pyogenic granuloma.

Anelah McGinness1, Amy Gillam2,3, Iwei Yeh3,4, Erin F Mathes3,5.   

Abstract

We present three patients with agminated pyogenic granulomas who experienced significant decrease in size and bleeding with treatment with topical timolol solution with minimal side effects. One patient had complete clinical resolution. For patients with agminated pyogenic granuloma who may otherwise have limited treatment options, timolol is an effective potential solution.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  hemangioma; pyogenic granuloma; therapy; topical; vascular tumor

Mesh：

Substances：

Year:  2018        PMID： 29961974     DOI： 10.1111/pde.13575

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  3 in total

1.  Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers.

Authors:  Jillian G Baker; Christophe Fromont; Marjorie Bruder; Kevin S J Thompson; Barrie Kellam; Stephen J Hill; Sheila M Gardiner; Peter M Fischer
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-01

2.  Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.

Authors:  Rohit Gupta; Logan DeBord; Harry Dao
Journal:  Cureus       Date:  2019-12-02

Review 3.  Topical beta-blockers in dermatologic therapy.

Authors:  Angela Filoni; Francesca Ambrogio; Aurora De Marco; Alessia Pacifico; Domenico Bonamonte
Journal:  Dermatol Ther       Date:  2021-06-21       Impact factor: 2.851
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.